Clinical Trial Update: Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia [NA]

View source ↗

Summary

This completed clinical trial evaluated nicotinic enhancement of cognitive remediation training in schizophrenia and schizoaffective disorder, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2019-04-08